Oxford University Press reveals its word of the year for 2025

Even if you don't know the meaning of the Oxford University Press' word of the year for 2025, you've probably been a victim of it on social media.

• Dec 1, 2025

Scientists digitally "unroll" ancient scroll scorched by Mount Vesuvius

Researchers used advanced technology to digitally "unroll" an ancient Greek text on carbonized papyrus, and now they're reading it.

• Feb 5, 2025

Chimpanzees seek out medicinal plants to treat ailments, study finds

Scientists monitoring 51 chimpanzees saw sick or injured animals eating certain plant items that were not part of their normal diet.

• Jun 21, 2024

Deaf girl's parents amazed as gene therapy lets her hear for first time

The parents of a U.K. toddler say it's "absolutely mind-blowing" to see their daughter, enrolled in a gene therapy trial, hear for the first time.

• May 10, 2024

China's balancing act amid Russia-Ukraine war

China has yet to condemn the Russian invasion of Ukraine, but Chinese officials have vowed to work toward de-escalation and say they will not offer miltary or financial aid to Moscow. George Magnus, research associate at the China Center at Oxford University, joined CBS News' Anne-Marie Green and Mola Lenghi to discuss how China's economic situation is affecting its stance on Ukraine.

• Mar 21, 2022
• 5:55

COVID-19 vaccine trial shows promising results

There are promising results on three different coronavirus vaccines, including the leading candidate from the U.K.'s Oxford University. Trials show it provides two kinds of protection against COVID-19. Charlie D'Agata has the latest.

• Jul 20, 2020
• 3:29

Shakespeare co-credit

Oxford University Press announced its new edition of Shakespeare's complete works will name Christopher Marlowe as a co-author. CBSN's Elaine Quijano has more on why this happened.

• Oct 24, 2016
• 0:34

New study may shed light on COVID blood clots

Research from Oxford University in England has new data regarding the rate of blood clotting cases in COVID-19 patients and vaccine recipients. The study, which has not been peer-reviewed yet, shows that the particular blood clot which was studied is eight to ten times more common in people who experience a COVID-19 infection than in people who were inoculated. Dr. David Agus joins "CBS This Morning" to explain the latest development.

• Apr 15, 2021
• 2:19

Kanye West had some fun with his speech at Oxford University

Kanye West had some fun with his speech at Oxford University. CBSN's Anne-Marie Greene and Vladimir Duthiers share the best moments of Kanye's speech captured on Twitter.

• Mar 2, 2015
• 0:43

Feds say AstraZeneca's COVID vaccine trial info may be "outdated"

As U.S. raises concerns over AstraZeneca's data reporting, drug company says preliminary info was "consistent with the interim analysis," but full review coming within 2 days.

• Mar 23, 2021

AstraZeneca says U.S. trial shows COVID vaccine 79% effective

The British drug maker says the large trial also answered many questions that have arisen about the vaccine. Next step: seeking approval for its use in the U.S.

• Mar 22, 2021

AstraZeneca hopes to file for COVID vaccine authorization within weeks

The drugmaker is working on a potential new vaccine that could be more effective against variants.

• Mar 5, 2021

Oxford vaccine may be key weapon against new COVID variants

The Oxford-AstraZeneca vaccine's "plug and play" platform means it's easy to modify, and scientists expect an update to fight new, troubling variants by the fall.

• Feb 27, 2021

Oxford University starts COVID-19 vaccine trial in children

The university has launched a study to assess the safety of its vaccine with AstraZeneca​ in children for the first time.

• Feb 14, 2021

EU regulator authorizes use of Oxford-AstraZeneca COVID vaccine

Blanket approval will be welcome news amid vaccine shortages across the bloc of 450 million people and worries about limited trial data for older adults.

• Jan 29, 2021

And then there were three: U.K. approves Moderna's COVID vaccine

But while it's authorized for use, the United Kingdom didn't place any early orders of this American coronavirus vaccine, so it won't be available to Brits until the spring.

• Jan 8, 2021

U.K. puts Oxford vaccine into action as COVID spreads fast

An 82-year-old dialysis patient and a scientist who helped develop the Oxford-AstraZeneca vaccine were among the first in the world to get the shot outside of trials.

• Jan 4, 2021

U.K. approves emergency use of Oxford-AstraZeneca COVID vaccine

Cheaper to make and easier to move than other approved vaccines, Oxford and AstraZeneca's formula becoming available as U.K. battles new virus variant.

• Dec 30, 2020

Oxford COVID vaccine shows promising results

Another potential coronavirus vaccine is showing promising results. Charlie D'Agata reports from Oxford University in England on the AstraZeneca vaccine trial.

• Nov 23, 2020
• 2:10

Vaccine trial halted after participant has possible adverse reaction

"This is a routine action which has to happen whenever there is a potentially unexplained illness in one of the trials," an AstraZeneca spokesperson said.

• Sep 9, 2020

First American to trial Oxford vaccine lost 7 relatives to virus

"I know there was a risk because it's like — it's a trial," 23-year-old Jacob Serrano said. "But I'd rather have us one step closer, no matter what it takes."

• Sep 2, 2020

The race for a coronavirus vaccine

Several companies are well into Phase 3 of their COVID-19 vaccine trials here in the U.S. Dr. Bob Lahita joins CBSN to discuss their progress, plus whether the coronavirus can be detected in America's wastewater.

• Aug 21, 2020
• 9:48

Oxford COVID vaccine trial results called "extremely encouraging"

AstraZeneca says the trial data "increases our confidence that the vaccine will work and allows us to continue our plans to manufacture the vaccine at scale."

• Jul 21, 2020

Oxford's coronavirus vaccine trial shows promise

NIH researchers in Montana tested a vaccine being developed by Oxford University using six rhesus macaque monkeys. They say the monkeys that got the vaccine developed protective antibodies against coronavirus. Dr. Jon LaPook reports.

• May 15, 2020
• 1:45

Human trials begin for COVID-19 vaccine

Human trials for a coronavirus vaccine are underway in Britain after group of scientists at Oxford University developed a formula they believe could stop the deadly virus. CBS News foreign correspondent Imtiaz Tyab reports from London.

• May 1, 2020
• 1:30

Show More